Constellation Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Constellation Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Constellation Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Constellation Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Constellation Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Constellation Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Mark A. Goldsmith, M.D., Ph.D.
Chairman Executive BoardMr. Mark A. Goldsmith has been the Chairman of the company since 2017. Prior to this, he was the President and Chief Executive Officer and Director of Revolution Medicines. Mr. Goldsmith also served as the Partner, President and Chief Executive Officer of Third Rock Ventures, LP, President and Chief Executive Officer of Global Blood Therapeutics, President and Chief Executive Officer of Nurix and Chief Executive Officer and Chairman of Cogentus Pharmaceuticals.
Jigar Raythatha
Chief Executive Officer; Director; President Executive BoardMr. Jigar Raythatha has been the President and Chief Executive Officer and Director of the company since 2017. Prior to this, he was the Chief Business Officer of Jounce Therapeutics, Inc. Mr. Raythatha also served as the Head of Corporate Development of Jounce Therapeutics, Inc.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer